The emerging role of FTY720 (Fingolimod) in cancer treatment
about
Sphingosine 1-phosphate signaling in bone remodeling: multifaceted roles and therapeutic potentialSphingosine kinase 1 is a potential therapeutic target for nasopharyngeal carcinoma.Inhibition of basal-like breast cancer growth by FTY720 in combination with epidermal growth factor receptor kinase blockade.Reprogramming the oncogenic response: SET protein as a potential therapeutic target in cancer.Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism.Core shell lipid-polymer hybrid nanoparticles with combined docetaxel and molecular targeted therapy for the treatment of metastatic prostate cancer.New FTY720-docetaxel nanoparticle therapy overcomes FTY720-induced lymphopenia and inhibits metastatic breast tumour growth.Sphingosine 1-phosphate receptor modulation suppresses pathogenic astrocyte activation and chronic progressive CNS inflammation.The expanding therapeutic armamentarium for inflammatory bowel disease: how to choose the right drug(s) for our patients?Decreased prevalence of cancer in patients with multiple sclerosis: A case-control study.Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain.A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors.A multicentric pharmacovigilance study: collection and analysis of adverse drug reactions in relapsing-remitting multiple sclerosis patients
P2860
Q33795328-243D4BB3-884C-4DCA-B2DF-3A0218F06166Q37697046-EB7A3C61-6A01-4921-8043-99F63A4CCF7AQ38640378-6BC3DCB0-357C-4468-9981-D1955E60FA47Q38678579-53014ABE-CB4A-414D-A629-537A6089577EQ38915115-9706000A-B526-4882-AA85-E62A7D7F6BBBQ41061525-7565AE97-CCDA-4CFF-BEBA-E4166321BA3DQ41899577-A04CB05C-41EB-46A0-ACAB-A887F9ABF4BEQ42234408-ACCD9919-2DD8-4DD2-A216-6A9B8945B5E1Q44581309-BDEEEEC4-3460-458F-A0D8-0B89087C83F8Q47094788-FD029DE1-C347-42FB-ADEE-4CEC7DD7E32DQ52691981-DAA91D5D-39E7-443B-9168-84295B86E6EDQ55001442-D45D3E03-3F12-4EB2-9ED6-8F2420B58808Q57491829-B74DCE7F-7F95-4A76-8331-07D5C0CA2078
P2860
The emerging role of FTY720 (Fingolimod) in cancer treatment
description
2016 nî lūn-bûn
@nan
2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
The emerging role of FTY720 (Fingolimod) in cancer treatment
@ast
The emerging role of FTY720 (Fingolimod) in cancer treatment
@en
The emerging role of FTY720 (Fingolimod) in cancer treatment
@nl
type
label
The emerging role of FTY720 (Fingolimod) in cancer treatment
@ast
The emerging role of FTY720 (Fingolimod) in cancer treatment
@en
The emerging role of FTY720 (Fingolimod) in cancer treatment
@nl
prefLabel
The emerging role of FTY720 (Fingolimod) in cancer treatment
@ast
The emerging role of FTY720 (Fingolimod) in cancer treatment
@en
The emerging role of FTY720 (Fingolimod) in cancer treatment
@nl
P2093
P2860
P921
P356
P1433
P1476
The emerging role of FTY720 (Fingolimod) in cancer treatment
@en
P2093
Christopher White
Colin Cooper
Matthias Winkler
P2860
P304
23106-23127
P356
10.18632/ONCOTARGET.7145
P407
P5008
P577
2016-04-26T00:00:00Z